M&A Deals Of Indian Drug Makers Heat Up In 2008
This article was originally published in PharmAsia News
Indian drug makers stepped up their merger and acquisition moves in April, eclipsing the value of similar deals in the first three months of this year. Eight acquisitions in the first three months of this year were valued at $152 million, but just two of the six April deals were valued at more than $473 million. The financial amounts of some of the deals have not been disclosed, including those of Dr. Reddy's Laboratories' leading acquisition activity over the four month period. (Click here for more
You may also be interested in...
In a bold move to expand into cancer treatment markets, Siemens Healthineers has agreed to a $16.4bn all-cash deal to acquire radiation therapy leader Varian.
Concern and skepticism about Russia's rapid vaccine roll-out. Meanwhile Japan is latest to reach reaches deal with Pfizer/BioNTech.
Sun’s Q1 earnings were dented by provisions related to the generic pricing investigation settlement with the US Department of Justice of arm Taro, and the impact of pandemic-related lockdowns. Some clinic-administered products bore the brunt of lock-downs in parts of the US, though market share was unaffected.